A Study to Assess the Clinical Outcomes of Surgical Phaco Segmentation Techniques in Patients Undergoing Cataract Surgery
NCT ID: NCT02843594
Last Updated: 2016-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
500 participants
INTERVENTIONAL
2016-08-31
2018-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retained Lens Fragments After Phacoemulsification
NCT02058394
Prospective Health Assessment of Cataract Patients' Ocular Surface
NCT01016405
A (Prospective/Pilot) Study Evaluating the Effect of Cataract Surgery on the Daily Activity Levels of Elderly Patients
NCT04074954
Cataract Surgery Technique and Ocular Clarity
NCT05489198
Strip Meniscometry in Dry Eye Evaluation
NCT06120894
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LEEP Intervention C1
Cataract surgery with micro-interventional LEEP technology lens fragmentation (non-randomized cohort 1)
LEEP intervention
Low Energy Endosafe Phaco (LEEP) with micro-interventional lens fragmentation
LEEP Intervention C2
Cataract surgery with micro-interventional LEEP technology lens fragmentation (randomized cohort 2)
LEEP intervention
Low Energy Endosafe Phaco (LEEP) with micro-interventional lens fragmentation
Control Phaco C2
Cataract surgery with conventional phaco-assisted lens fragmentation (randomized cohort 2)
Standard Phaco Control
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LEEP intervention
Low Energy Endosafe Phaco (LEEP) with micro-interventional lens fragmentation
Standard Phaco Control
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subjects with a visually significant cataract scheduled to undergo cataract surgery
3. Subjects \> 18 years of age
4. BCVA at baseline not better than 20/40
5. Grade 1+ cataracts
Exclusion Criteria
2. Subjects \< 18 years of age
3. Polar cataracts
4. Zonular instability
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Iantech, Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinica de Ojos Panama City
Panama City, , Panama
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Ianchulev T, Chang DF, Koo E, MacDonald S, Calvo E, Tyson FT, Vasquez A, Ahmed IIK. Microinterventional endocapsular nucleus disassembly: novel technique and results of first-in-human randomised controlled study. Br J Ophthalmol. 2019 Feb;103(2):176-180. doi: 10.1136/bjophthalmol-2017-311766. Epub 2018 Apr 18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LEEP103
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.